Industry News
Biotechnology Industry News
The Importance of the Patient in Advancing Care in Rare Diseases
The Importance of the Patient in Advancing Care in Rare Diseases mwen Tue, 02/22/2022 - 10:41
Adagio CEO resigns with no explanation and the biotech plans COVID-19 antibody analysis this quarter
Adagio CEO resigns with no explanation and the biotech plans COVID-19 antibody analysis this quarter klahucik Tue, 02/22/2022 - 10:09
Building off Prevail buy, Lilly to construct $700 million Boston research hub in gene therapy blitz
Building off Prevail buy, Lilly to construct $700 million Boston research hub in gene therapy blitz mbayer Tue, 02/22/2022 - 09:41
Building off Prevail buy, Lilly to construct $700M Boston research hub in gene therapy blitz
Building off Prevail buy, Lilly to construct $700M Boston research hub in gene therapy blitz mbayer Tue, 02/22/2022 - 09:41
Moderna’s RSV shot sails on to phase 3, tightening Big Pharma battle royale
Moderna's RSV shot sails on to phase 3, tightening Big Pharma battle royale aarmstrong Tue, 02/22/2022 - 09:20
Takeda’s gene therapy ambitions rise another $2B in 4-program Code Bio pact
Takeda's gene therapy ambitions rise another $2B in 4-program Code Bio pact klahucik Tue, 02/22/2022 - 08:36
BioNTech jumps into PRAME game, paying Medigene $29M for preclinical T-cell therapy program
BioNTech jumps into PRAME game, paying Medigene $29M for preclinical T-cell therapy program ntaylor Tue, 02/22/2022 - 05:57
Synairgen’s pivotal COVID-19 SPRINTER trial falls at final hurdle, sending stock into downward spiral
Synairgen's pivotal COVID-19 SPRINTER trial falls at final hurdle, sending stock into downward spiral ntaylor Tue, 02/22/2022 - 04:49
Atara, Memorial Sloan Kettering investigating patient death in phase 1 mesothelioma CAR-T study
Atara, Memorial Sloan Kettering investigating patient death in phase 1 mesothelioma CAR-T study klahucik Fri, 02/18/2022 - 13:05
Ribon taps former Novartis VP, Flagship partner Raman as CEO
Ribon taps former Novartis VP, Flagship partner Raman as CEO mbayer Fri, 02/18/2022 - 10:19
Ligand to spin off J&J-partnered antibody unit with $70M in funding
Ligand to spin off J&J-partnered antibody unit with $70M in funding klahucik Fri, 02/18/2022 - 09:35
FDA grounds BioMarin gene therapy trial for months with demand for tumor risk data
FDA grounds BioMarin gene therapy trial for months with demand for tumor risk data ntaylor Fri, 02/18/2022 - 06:13
GSK, in close race with Pfizer, slams brakes on phase 3 maternal RSV vaccine program over safety signal
GSK, in close race with Pfizer, slams brakes on phase 3 maternal RSV vaccine program over safety signal ntaylor Fri, 02/18/2022 - 05:04
‘Early stage’: Majority of biotechs don’t disclose ESG practices, but most plan to in near term
'Early stage': Majority of biotechs don't disclose ESG practices, but most plan to in near term klahucik Thu, 02/17/2022 - 11:23
After clinical hold, Yumanity to cut 60% of workforce by April and hunt for a buyer
After clinical hold, Yumanity to cut 60% of workforce by April and hunt for a buyer mbayer Thu, 02/17/2022 - 10:56
Recommended Strategies for Your Next Biomarker-Driven Clinical Trial
Recommended Strategies for Your Next Biomarker-Driven Clinical Trial mwen Thu, 02/17/2022 - 09:40
Ex-NIH chief Collins returns as science adviser to Biden weeks into retirement
Ex-NIH chief Collins returns as science adviser to Biden weeks into retirement klahucik Thu, 02/17/2022 - 09:35
Innovent’s phase 3 hits tee it up to challenge Amgen and Sanofi for Chinese PCSK9 market
Innovent's phase 3 hits tee it up to challenge Amgen and Sanofi for Chinese PCSK9 market ntaylor Thu, 02/17/2022 - 09:14
Billionaire’s fund backs Heidelberg to carve out niche in busy BCMA space
Billionaire's fund backs Heidelberg to carve out niche in busy BCMA space ntaylor Thu, 02/17/2022 - 07:56
Remix Therapeutics signs Janssen licensing deal that could top $1B
Remix Therapeutics signs Janssen licensing deal that could top $1B mbayer Wed, 02/16/2022 - 18:00